October 2018 Performance
October was simply an awful month with my portfolio generating a net loss of 8.78%. Nothing worked for me at all and I have to admit that my confidence was shaken a bit. I had a decent position in CA Technologies with short Puts and I fell for the fraudulent memo leak by closing out my position at a nice loss. I decided it was time regroup by going small and to slowly rebuild my confidence.
So onto my merger arb plays. I closed out my position in SodaStream (short Puts)
for a small gain. I initiated small positions in Café Press and Senomyx. These
were microcap companies and it was extremely difficult to build a decent
position. I only managed to build a small position in both of these companies.
Senomyx actually closed today and Café Press should close next week. I like
these microcap merger plays as they often fall under the radar and can offer
decent annualized returns with a quick closing (both of these were structured
as tender offers).
Today, I initiated a
small starter position in Pacific Biosciences via Short Puts. Pacific Biosciences
is being acquired by Illumina for $8.00 per share in cash. Pacific Biosciences
is currently trading at ~ $7.50, which gives you a gross spread of ~ 6% (~12%
annualized return based on a closing in 6 months). I don’t see much of a
regulatory risk in this deal as Pacific Biosciences is essentially a tiny fish
in the sequencing space. The big players are Illumina and Life Technologies (Ion
Torrent and Applied Biosystems).
I have not done much with my long
positions (Apple, Alibaba, Constellation Brands, MasterCard, Qiagen, Sanofi and
Visa). I continue to add to my Constellation Brands position with this recent
decline. Their Q2 earnings were impressive as beer, spirits and even wine
performed well. I am starting to become more bullish with their stake in Canopy
Growth and the enormous market this can represent.
Hoping to just end the year green at
this point!
2018 Performance = +10.92% with the
running monthly returns as follows:
January +2.80%
February +2.82%
March -0.03%
April +2.10%
May +6.25%
June -1.51%
July +1.53%
January +2.80%
February +2.82%
March -0.03%
April +2.10%
May +6.25%
June -1.51%
July +1.53%
August +5.1%
September -0.60%
October -8.78%
15 Comments:
SODA: Whatever happened to HSR approval? Is that the reason you bailed out or just being conservative
SODA: Just being conservative. I really have no concerns with anti trust approval with this one.
RCII earnings looking ok... might be relatively safe play from here
RCII: Yes, I agree. I may get back in...
AET / CVS - just cleared California with concessions. It's another cigarette butt with 1% spread left if merger close as scheduled by thanksgiving next week.
Thanks for the AET / CVS update.
a little bit of delay as now closing is scheduled after thanksgiving with NJ giving approval yesterday. Now the only approval left is New York. Co-incidentally, NY scheduled CI/ESRX hearing on 7 Dec so i presume NY will start on CI/ESRX after CVS/AET approval. This gives the latest decision date to before 7 Dec (2 weeks) but i m optimistic we will get approval by next week. The spread widens abit to 1.7% with market turmoil which is still a good cig butt.
previous reports have NY pushing CVS/AET for no premium increase due to merger and concessions which CVS/AET had reportedly given to California so i think CVS/AET is in a good position for final approval.
CVS/AET closed. CI/ESRX still about 1.5 months out
Merger Pie, Thanks for the updates once again...
Is TSRO good arb play, lots of competition in parpi
TSRO: I initiated a position today via short Puts. I see this deal closing fast (deal structured as a tender offer) and don't see antitrust issues. Lots of competition is a good thing from an antitrust perspective.
Is TSRO likely to close some time January?
TSRO: Yes, I believe a close in January is a high likely hood. We'll get a better idea of the exact date when they commence the tender offer (within the next 10 biz days).
For those interested in CI/ESRX merger, NY DFS hearing has been rescheduled to 10th Jan 2018.
Post a Comment
<< Home